George A. Eldridge

Insider Reports History

Entity
Individual
Location
C/O Targanta Therapeutics Corporation, 222 Third Street Suite 2300, Cambridge, MA
Signature
/s/ George A. Eldridge
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George A. Eldridge:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. Officer Title: Chief Financial Officer and Treasurer Stock Option (Right to Buy) 28.8K $471K $16.37 Jun 14, 2024 Direct
Aerovate Therapeutics, Inc. Officer Title: Chief Financial Officer and Treasurer Common Stock 5.02K $126K $25.03 Jun 14, 2024 Direct

Insider Reports Filed by George A. Eldridge

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTE Aerovate Therapeutics, Inc. Jun 14, 2024 3 -$343K 4 Jun 14, 2024 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Apr 10, 2024 4 -$185K 4 Apr 12, 2024 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Apr 1, 2024 3 -$363K 4 Apr 3, 2024 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Mar 12, 2024 6 -$93.1K 4 Mar 14, 2024 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Mar 7, 2024 11 -$594K 4 Mar 11, 2024 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Jan 22, 2024 1 $0 4 Jan 24, 2024 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Feb 7, 2023 1 $0 4 Feb 8, 2023 Officer
AVTE Aerovate Therapeutics, Inc. Dec 9, 2022 8 -$367K 4 Dec 13, 2022 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Dec 7, 2022 10 -$466K 4 Dec 9, 2022 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Nov 30, 2022 3 -$1.44K 4 Dec 2, 2022 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Nov 23, 2022 3 -$21.3K 4 Nov 28, 2022 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Nov 18, 2022 10 -$17.9K 4 Nov 22, 2022 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Dec 14, 2021 1 $0 4 Dec 16, 2021 Officer Title: Chief Financial Officer and Treasurer
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 Officer Title: Chief Financial Officer and Treasurer Exhibit 24 - Power of Attorney
AVTE Aerovate Therapeutics, Inc. Apr 2, 2021 3 $0 4 Jul 1, 2021 Officer Title: Chief Financial Officer and Treasurer